Cargando…

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series

Detalles Bibliográficos
Autores principales: Oliveira, Jennifer L., Greipp, Patricia T., Rangan, Aruna, Jatoi, Aminah, Nguyen, Phuong L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789926/
https://www.ncbi.nlm.nih.gov/pubmed/35078980
http://dx.doi.org/10.1038/s41408-022-00607-7
_version_ 1784639886133821440
author Oliveira, Jennifer L.
Greipp, Patricia T.
Rangan, Aruna
Jatoi, Aminah
Nguyen, Phuong L.
author_facet Oliveira, Jennifer L.
Greipp, Patricia T.
Rangan, Aruna
Jatoi, Aminah
Nguyen, Phuong L.
author_sort Oliveira, Jennifer L.
collection PubMed
description
format Online
Article
Text
id pubmed-8789926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87899262022-02-07 Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series Oliveira, Jennifer L. Greipp, Patricia T. Rangan, Aruna Jatoi, Aminah Nguyen, Phuong L. Blood Cancer J Correspondence Nature Publishing Group UK 2022-01-25 /pmc/articles/PMC8789926/ /pubmed/35078980 http://dx.doi.org/10.1038/s41408-022-00607-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Oliveira, Jennifer L.
Greipp, Patricia T.
Rangan, Aruna
Jatoi, Aminah
Nguyen, Phuong L.
Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title_full Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title_fullStr Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title_full_unstemmed Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title_short Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series
title_sort myeloid malignancies in cancer patients treated with poly(adp-ribose) polymerase (parp) inhibitors: a case series
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789926/
https://www.ncbi.nlm.nih.gov/pubmed/35078980
http://dx.doi.org/10.1038/s41408-022-00607-7
work_keys_str_mv AT oliveirajenniferl myeloidmalignanciesincancerpatientstreatedwithpolyadpribosepolymeraseparpinhibitorsacaseseries
AT greipppatriciat myeloidmalignanciesincancerpatientstreatedwithpolyadpribosepolymeraseparpinhibitorsacaseseries
AT ranganaruna myeloidmalignanciesincancerpatientstreatedwithpolyadpribosepolymeraseparpinhibitorsacaseseries
AT jatoiaminah myeloidmalignanciesincancerpatientstreatedwithpolyadpribosepolymeraseparpinhibitorsacaseseries
AT nguyenphuongl myeloidmalignanciesincancerpatientstreatedwithpolyadpribosepolymeraseparpinhibitorsacaseseries